{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:21:15Z","timestamp":1787818875230,"version":"build-2784847793"},"reference-count":55,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:00:00Z","timestamp":1787702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research Training Program (RTP) Stipend Scholarship"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background &amp; Aims: One-carbon metabolism plays a central role in neurotransmitter synthesis, methylation capacity, and neurobiological resilience. Variants in the methylenetetrahydrofolate reductase (MTHFR) gene can reduce enzymatic activity, affecting folate- and methionine-cycle functions and potentially influencing biological pathways relevant to mood and anxiety disorders. Personalised nutraceutical treatment strategies, particularly those addressing methylation capacity through targeted B-vitamin, folate, and adjunctive metabolic interventions are increasingly implemented in integrative clinical practice, yet evidence regarding their clinical outcomes remains limited. Methods: We conducted a retrospective cohort study of 50 adults attending an integrative general practice clinic for anxiety and\/or depression. All received personalised nutraceutical treatment informed by clinical assessment, laboratory testing and, for 37\/50 patients, MTHFR genotyping. Psychological distress was measured using the Kessler-10 (K10) scale at baseline and approximately three months later. Secondary analyses evaluated whether outcomes differed by MTHFR genotype, whether specific supplements (e.g., L-methylfolate and SAMe) were associated with greater improvement, whether biomarker changes correlated with symptom change, and the safety\/tolerability profile. Results: Across the full cohort, mean K10 scores significantly decreased by four points over the treatment period, with 72% of patients showing clinical improvement. Reductions in psychological distress were seen across all MTHFR genotypes, including individuals with homozygous variant genotypes. Supplement-specific analyses showed improvement among those receiving methylfolate or SAMe, although the differences were not statistically significant. Following nutraceutical treatment, biomarker analyses demonstrated significant increases in serum vitamin B12 and modest reductions in homocysteine, but biomarker shifts did not correlate strongly with K10 change. No serious adverse events or clinically significant abnormalities in liver or renal function were identified. Conclusions: In this real-world primary care cohort, personalised nutraceutical treatment, grounded in one-carbon metabolism support and applied alongside usual care, was associated with clinically meaningful reductions in psychological distress. Outcomes were comparable across MTHFR genotypes when treatments were appropriately tailored, suggesting that genotype and biomarker-informed nutraceutical strategies may mitigate potential metabolic disadvantages. These findings support further controlled research into precision nutraceutical psychiatry for anxiety and depression. Secondary analyses of genotype subgroup, specific supplements, and biomarker\u2013outcome associations are reported alongside Benjamini\u2013Hochberg FDR-adjusted p-values and should be interpreted as hypothesis-generating.<\/jats:p>","DOI":"10.3390\/nu18172791","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:59:57Z","timestamp":1787749197000},"page":"2791","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalised Nutraceutical Treatment Guided by MTHFR Genotype in Mental Health: A Retrospective Cohort Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Cristina","family":"Beer","sequence":"first","affiliation":[{"name":"Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9276-0076","authenticated-orcid":false,"given":"Fiona","family":"Rae","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikayla","family":"Watt","sequence":"additional","affiliation":[{"name":"Cris Medical Services, Robina, QLD 4226, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Trzaskowski","sequence":"additional","affiliation":[{"name":"Ketim Technologies, Brisbane City, QLD 4000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9578-5634","authenticated-orcid":false,"given":"Clarissa","family":"Yates","sequence":"additional","affiliation":[{"name":"Ketim Technologies, Brisbane City, QLD 4000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-4986","authenticated-orcid":false,"given":"Annalese","family":"Semmler","sequence":"additional","affiliation":[{"name":"School of Clinical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6645-6164","authenticated-orcid":false,"given":"Joanne","family":"Voisey","sequence":"additional","affiliation":[{"name":"Centre for Genomics and Personalised Health, School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Kelvin Grove, QLD 4059, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"GBD 2019 Mental Disorders Collaborators (2022). Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry, 9, 137\u2013150.","DOI":"10.1016\/S2215-0366(21)00395-3"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","article-title":"Adjunctive nutraceuticals for depression: A systematic review and meta-analyses","volume":"173","author":"Sarris","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4088\/JCP.8133su1c.02","article-title":"Identifying difficult-to-treat depression: Differential diagnosis, subtypes, and comorbidities: Differential diagnosis, subtypes, and comorbidities","volume":"70","author":"Gaynes","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jad.2018.08.056","article-title":"The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis","volume":"241","author":"Rosenblat","year":"2018","journal-title":"J. Affect. Disord."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3892\/wasj.2025.321","article-title":"Pharmacogenetic-guided treatment in major depressive disorder","volume":"7","author":"Panagiotou","year":"2025","journal-title":"World Acad. Sci. J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1753-4887.1996.tb03851.x","article-title":"Folate, vitamin B12, and neuropsychiatric disorders","volume":"54","author":"Bottiglieri","year":"1996","journal-title":"Nutr. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1097\/00001756-200507130-00005","article-title":"Folate deficiency inhibits proliferation of adult hippocampal progenitors","volume":"16","author":"Kruman","year":"2005","journal-title":"Neuroreport"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/070674371205700703","article-title":"Folates and S-adenosylmethionine for major depressive disorder","volume":"57","author":"Papakostas","year":"2012","journal-title":"Can. J. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1158S","DOI":"10.1093\/ajcn\/76.5.1158S","article-title":"Role of S-adenosyl-l-methionine in the treatment of depression: A review of the evidence","volume":"76","author":"Mischoulon","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jimd.12009","article-title":"Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation","volume":"42","author":"Froese","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2382S","DOI":"10.1093\/jn\/132.8.2382S","article-title":"Gene-nutrient interactions and DNA methylation","volume":"132","author":"Friso","year":"2002","journal-title":"J. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","article-title":"A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity","volume":"64","author":"Weisberg","year":"1998","journal-title":"Mol. Genet. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.12788\/cp.0052","article-title":"Impact of the MTHFR C677T genetic variant on depression","volume":"19","author":"Lipp","year":"2020","journal-title":"Curr. Psychiatry"},{"key":"ref_14","first-page":"53","article-title":"The role of folate and MTHFR polymorphisms in the treatment of depression","volume":"27","author":"Stengler","year":"2021","journal-title":"Altern. Ther. Health Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"14853","DOI":"10.1073\/pnas.261469998","article-title":"Effects of common polymorphisms on the properties of recombinant human methylenetetrahydrofolate reductase","volume":"98","author":"Yamada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"K2","DOI":"10.1186\/2049-3258-72-S1-K2","article-title":"Riboflavin lowers blood pressure in hypertensive people with the MTHFR677TT genotype","volume":"72","author":"McNulty","year":"2014","journal-title":"Arch. Public Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1001\/archpsyc.60.6.618","article-title":"Folate, vitamin B12, homocysteine, and the MTHFR 677C\u2192T polymorphism in anxiety and depression: The Hordaland Homocysteine Study: The Hordaland Homocysteine Study","volume":"60","author":"Bjelland","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.nut.2007.10.013","article-title":"Dietary intake of folate, other B vitamins, and omega-3 polyunsaturated fatty acids in relation to depressive symptoms in Japanese adults","volume":"24","author":"Murakami","year":"2008","journal-title":"Nutrition"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jad.2013.07.012","article-title":"Homocysteine, depression and cognitive function in older adults","volume":"151","author":"Ford","year":"2013","journal-title":"J. Affect. Disord."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12991-020-00298-z","article-title":"S-Adenosylmethionine (SAMe) in major depressive disorder (MDD): A clinician-oriented systematic review","volume":"19","author":"Cuomo","year":"2020","journal-title":"Ann. Gen. Psychiatry"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Araszkiewicz, A.F., Ja\u0144czak, K., W\u00f3jcik, P., Bia\u0142ecki, B., Kubiak, S., Szczechowski, M., and Januszkiewicz-Lewandowska, D. (2025). MTHFR gene polymorphisms: A single gene with wide-ranging clinical implications\u2014A review. Genes, 16.","DOI":"10.20944\/preprints202503.1383.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2013.06.015","article-title":"Association between MTHFR C677T polymorphism and depression: An updated meta-analysis of 26 studies","volume":"46","author":"Wu","year":"2013","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.bbi.2010.12.006","article-title":"Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: Evidence for a common genetic vulnerability?","volume":"25","author":"Peerbooms","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40364-015-0028-1","article-title":"Biomarkers of a five-domain translational substrate for schizophrenia and schizoaffective psychosis","volume":"3","author":"Strobel","year":"2015","journal-title":"Biomark. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ymgme.2015.01.013","article-title":"Tetrahydrobiopterin (BH4) responsiveness in neonates with hyperphenylalaninemia: A semi-mechanistically-based, nonlinear mixed-effect modeling","volume":"114","author":"Trefz","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1471-4159.2001.00384.x","article-title":"Homocysteine potentiates beta-amyloid neurotoxicity: Role of oxidative stress","volume":"78","author":"Ho","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1146\/annurev-nutr-071715-050947","article-title":"Homocysteine, B vitamins, and cognitive impairment","volume":"36","author":"Smith","year":"2016","journal-title":"Annu. Rev. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.pnpbp.2005.06.026","article-title":"Homocysteine and brain atrophy","volume":"29","author":"Sachdev","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ana.22189","article-title":"B-vitamins reduce the long-term risk of depression after stroke: The VITATOPS-DEP trial","volume":"68","author":"Almeida","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1002\/fsn3.4073","article-title":"Folate supplementation as a beneficial add-on treatment in relieving depressive symptoms: A meta-analysis of meta-analyses","volume":"12","author":"Gao","year":"2024","journal-title":"Food Sci. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.euroneuro.2017.07.004","article-title":"Efficacy of adding nutritional supplements in unipolar depression: A systematic review and meta-analysis","volume":"27","author":"Schefft","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1176\/appi.ajp.2012.11071114","article-title":"L-methylfolate as adjunctive therapy for SSRI-resistant major depression: Results of two randomized, double-blind, parallel-sequential trials","volume":"169","author":"Papakostas","year":"2012","journal-title":"Am. J. Psychiatry"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1055\/a-1681-2047","article-title":"Systematic review and meta-analysis of L-methylfolate augmentation in depressive disorders","volume":"55","author":"Maruf","year":"2022","journal-title":"Pharmacopsychiatry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4088\/JCP.15m10181","article-title":"Long-term efficacy, safety, and tolerability of L-methylfolate calcium 15 mg as adjunctive therapy with selective serotonin reuptake inhibitors: A 12-month, open-label study following a placebo-controlled acute study: A 12-month, open-label study following a placebo-controlled acute study","volume":"77","author":"Zajecka","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/nu2030299","article-title":"Vitamin B12 in health and disease","volume":"2","author":"Samman","year":"2010","journal-title":"Nutrients"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1749-6632.1990.tb28049.x","article-title":"Neurobiology of pyridoxine","volume":"585","author":"Dakshinamurti","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S0029665116000197","article-title":"Riboflavin status, MTHFR genotype and blood pressure: Current evidence and implications for personalised nutrition","volume":"75","author":"McAuley","year":"2016","journal-title":"Proc. Nutr. Soc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"110985","DOI":"10.1016\/j.pnpbp.2024.110985","article-title":"Efficacy and acceptability of S-adenosyl-L-methionine (SAMe) for depressed patients: A systematic review and meta-analysis","volume":"132","author":"Limveeraprajak","year":"2024","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00213-019-05358-1","article-title":"S-Adenosylmethionine (SAMe) monotherapy for depression: An 8-week double-blind, randomised, controlled trial","volume":"237","author":"Sarris","year":"2020","journal-title":"Psychopharmacology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0404.1994.tb05403.x","article-title":"S-adenosyl-l-methionine (SAMe) as antidepressant: Meta-analysis of clinical studies","volume":"154","author":"Bressa","year":"1994","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.biopsych.2013.05.008","article-title":"Zinc in depression: A meta-analysis","volume":"74","author":"Swardfager","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tarleton, E.K., Littenberg, B., MacLean, C.D., Kennedy, A.G., and Daley, C. (2017). Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180067"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1038\/tp.2016.29","article-title":"Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder","volume":"6","author":"Mocking","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1503\/jpn.100057","article-title":"N-acetylcysteine in psychiatry: Current therapeutic evidence and potential mechanisms of action","volume":"36","author":"Dean","year":"2011","journal-title":"J. Psychiatry Neurosci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2215-0366(14)00051-0","article-title":"Nutritional medicine as mainstream in psychiatry","volume":"2","author":"Sarris","year":"2015","journal-title":"Lancet Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"P3.9-057","DOI":"10.1212\/WNL.92.15_supplement.P3.9-057","article-title":"Effect of L-methylfolate on depressive symptoms in patients with MTHFR mutations (P3.9-057)","volume":"92","author":"Rainka","year":"2019","journal-title":"Neurology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"162","DOI":"10.64062\/JPGMB.Vol1.Issue4.14","article-title":"Major Depressive Disorder (MDD), Pharmacogenomics, Antidepressant Therapy, Personalized Medicine, CYP2D6, CYP2C19","volume":"1","author":"Meena","year":"2025","journal-title":"J. Pharmacol. Genet. Mol. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1017\/S0033291702006074","article-title":"Short screening scales to monitor population prevalences and trends in non-specific psychological distress","volume":"32","author":"Kessler","year":"2002","journal-title":"Psychol. Med."},{"key":"ref_49","unstructured":"R Core Team (2024). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing. Available online: https:\/\/www.R-project.org\/."},{"key":"ref_50","unstructured":"Fox, J., and Weisberg, S. (2019). An R Companion to Applied Regression, SAGE Publications. [3rd ed.]."},{"key":"ref_51","unstructured":"Torchiano, M. (2025, September 18). R Package, Available online: https:\/\/CRAN.R-project.org\/package=effsize."},{"key":"ref_52","unstructured":"Champely, S. (2025, September 18). R Package, Available online: https:\/\/CRAN.R-project.org\/package=pwr."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Fryar-Williams, S. (2016). Fundamental role of methylenetetrahydrofolate reductase 677 C \u2192 T genotype and flavin compounds in biochemical phenotypes for schizophrenia and schizoaffective psychosis. Front. Psychiatry, 7.","DOI":"10.3389\/fpsyt.2016.00172"},{"key":"ref_55","first-page":"CD011286","article-title":"S-adenosyl methionine (SAMe) for depression in adults","volume":"10","author":"Galizia","year":"2016","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/17\/2791\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T08:11:14Z","timestamp":1787818274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/17\/2791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,26]]},"references-count":55,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["nu18172791"],"URL":"https:\/\/doi.org\/10.3390\/nu18172791","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,26]]}}}